Back

Who we are

With research staff from more than 70 countries, and offices across the globe, IFPRI provides research-based policy solutions to sustainably reduce poverty and end hunger and malnutrition in developing countries.

David Spielman

David Spielman is the director of IFPRI’s Innovation Policy and Scaling Unit and has been with the institute since 2004. His research agenda covers a range of topics including agriculture and rural development policy; agricultural science, technology, and innovation; plant genetic resources and seed systems; agricultural extension and advisory services; and community-driven rural development.

Back

What we do

Since 1975, IFPRI’s research has been informing policies and development programs to improve food security, nutrition, and livelihoods around the world.

Where we work

Back

Where we work

IFPRI currently has more than 480 employees working in over 70 countries with a wide range of local, national, and international partners.

IFPRI Roundtable on Next Harvest II

Biotechnology Capacity in Africa, A Way Forward

DC

International Food Policy Research Institute

2033 K Street, NW, Washington, DC Fourth Floor Conference Facility

Washington, United States

February 20, 2015

  • 5:00 – 7:00 pm (America/New_York)
  • 11:00 – 1:00 am (Europe/Amsterdam)
  • 3:30 – 5:30 am (Asia/Kolkata)

IFPRI’s 2014 report “GM Technologies for Africa: A State of Affairs” identified the lack of standardized and uniformly collected biotech data as a main constraint in assessing the overall state of Africa’s agricultural biotechnology capacity and in the ability to draw policy recommendations regarding countries’ strengths and needs. IFPRI designed and implemented Next Harvest II, a John Templeton funded initiative that gathered detailed information for four of the leading biotechnology countries in Africa: Kenya, Nigeria, South Africa, and Uganda. The information collected has enabled the systematic evaluation of the status of African biotechnologies in these countries. A panel of participants will give an overview of the results for each country, highlighting their differences and similarities, and will discuss the capacity of the biotechnology innovation system to produce and deliver these technologies, the opportunities and challenges faced, and will give policy recommendations to address current limitations.

Go-to-Meeting available for those unable to join the meeting in Washington, DC. Please contact Pilar Rickert (p.rickert@cgiar.org) for more information.